Phorm Corporation Limited Notice of Annual General Meeting and Board Changes (6913K)
27 June 2014 - 4:06PM
UK Regulatory
TIDMPHRM
RNS Number : 6913K
Phorm Corporation Limited
27 June 2014
27 June 2014
Phorm Corporation Limited
("Phorm" or the "Company")
Notice of Annual General Meeting and Board Changes
Phorm (AIM: PHRM), a leading internet personalisation technology
company, announces that its forthcoming Annual General Meeting
("AGM") will be held at 11.00 a.m. (London time) on Thursday 24
July 2014 at the offices of Hogan Lovells International LLP,
Atlantic House, Holborn Viaduct, London EC1A 2FG.
The formal notice convening and outlining details of the AGM is
being posted to shareholders today and, once posted, will also be
made available to download from the Investor Relations section of
the Company's website at www.phorm.com.
Board Changes
Phorm is also pleased to announce that Mr Johannes Minho Roth
will be appointed as a Non-Executive Director of the Company on 24
July 2014, subject to shareholders' approval at the abovementioned
AGM. Mr Roth is the founding director and partner at FiveT Capital
Holding AG, a Switzerland-based innovative financial holdings firm.
He has many years experience of international markets and
technology businesses including acting as Chief Executive Officer
at FiveT Capital AG and as an equity specialist and proprietary
trader at Baaderbank AG. Mr Roth also holds a Masters degree
(diploma) in Economics from Hohenheim University, in Germany.
In addition, the Company announces that Christophe Delorme will
step down from the Board with effect from the conclusion of the
abovementioned AGM to focus on his other business interests,
including his role as CEO of NFT Investment PTE Ltd.
Kent Ertugrul, Chairman and CEO of Phorm commented:
"We are delighted to welcome Johannes to the Phorm Board. His
valuable experience of international markets and technology
businesses will assist with the group's future growth and
development.
"We are grateful for the important contribution Christophe has
made to Phorm and wish him well in his future endeavours.
"The composition of the Board is reviewed on a regular basis and
it remains our intention to appoint an independent Chairman at the
appropriate stage in the Company's commercial development."
Additional information on Mr Johannes Minho Roth
The following additional information is provided in accordance
with paragraph (g) of Schedule Two to the AIM Rules for
Companies:
Johannes Minho Roth (aged 35)
Current Directorships/Partnerships Past Directorships/Partnerships
(last 5 years)
FiveT Capital Holding None
AG
FiveT Capital AG
Insilico Biotechnology
AG
Plug Power, Inc.
Amorfix Life Sciences
Ltd
Fanorakel AG
As noted above, Mr Roth is the founding director and partner at
FiveT Capital AG which is currently interested in 25,545,000
ordinary shares of nil par value each in the capital of Phorm,
representing approximately 4.12 per cent. of the Company's existing
issued share capital.
There is no other information that is required to be disclosed
pursuant to paragraph (g) of Schedule Two to the AIM Rules for
Companies.
-Ends-
For further information please contact:
Phorm Corporation Limited
Andy Croxson (analysts and investors) +44 (0) 203 397 6001
UK Investors
Mirabaud Securities LLP (Broker) +44 20 7321 2508
Jason Woollard
Peter Krens
Strand Hanson Limited (Nominated Adviser) +44 20 7409 3494
James Harris
Matthew Chandler
James Dance
US Investors
Lippert/Heilshorn and Associates (Investor Relations) +1 212 838 3777
John Heilshorn
About Phorm
Phorm is a global personalisation technology company that makes
content and advertising more relevant to the consumer. Phorm's
innovative platform preserves user privacy and delivers a more
interesting online experience.
Phorm's industry leading technology enables its Internet Service
Provider ("ISP") partners to offer a new type of online advertising
platform and a free consumer internet content feature, ensuring
more relevant advertisements and personalised content for opted-in
users.
Phorm's advertising platform revolutionises current standards of
online privacy, fully protecting the identity of consumers. Phorm's
solution is completely opt-in. Only those users consenting to the
service are profiled and only ever on an anonymous basis.
Phorm's partners include leading ISPs, Publishers, Advertising
Networks and Advertisers.
Phorm, under a predecessor holding company, was admitted to the
AIM market of the London Stock Exchange in 2004.
For more information, please visit: www.phorm.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCMMGZVNVMGDZM
Phorm Corp (LSE:PHRM)
Historical Stock Chart
From Jun 2024 to Jul 2024
Phorm Corp (LSE:PHRM)
Historical Stock Chart
From Jul 2023 to Jul 2024